According to the above data, the selective agonists of the GABA-A receptor complex are the drugs of first choice in the drug treatment of insomnia. [22] Once treatment has started, monitoring and ...

According to the South China Morning Post, he caused his girlfriend's death by attempting to treat her insomnia with repeated ...

Eisai has launched its insomnia drug Dayvigo in Japan, the second in a new class of medicines after Merck & Co’s Belsomra, which made its debut there in 2014. Dayvigo (lemborexant) is a dual ...

Seltorexant "is unique," as there are currently no other antidepressants or insomnia therapies with the same mechanism of action, said Krystal, adding that if the FDA approves the drug ...

Imagine being able to "turn off" your racing thoughts with a 40-second burst of magnetic pulses. New technology may soon make ...

Medically reviewed by Jenny Sweigard, MD Primary insomnia is a condition characterized by difficulty sleeping. Unlike ...

Drug overdose could be fatal ... of Sleep Medicine doesn’t recommend it as a first line of treatment for insomnia. Consider speaking with a healthcare professional about ways to improve your ...

Insomnia is a lot more prevalent than people think it is. Besides the usual remedies, generative AI now comes to the rescue.

Chronic insomnia — defined as sleeplessness that occurs at least three times per week for at least 3 months — affects about 10 percent of adults. Medication is available to treat chronic insomnia.

Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.

As with other drugs, Wakix can cause side effects, such as insomnia and nausea. Wakix can cause certain side effects, some of which are more common than others. These side effects may be temporary ...